Progenics Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

NEXT STORY
Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018
PREV STORY
BeyondSpring to Present Neutropenia Clinical Trial Data on Lead Asset, Plinabulin, at 2018 ASCO Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Translate Bio Announces Fourth Quarter and Full Year 2018 Financial Results and Reviews Recent Highlights

author_avatar
NASDAQ Market News

INVENTIVA : FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study of Lanifibranor in Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease

                                                                       FDA Approval of an Investigator Initiated IND Application to Conduct Phase II Study ...

author_avatar
NASDAQ Market News

Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

author_avatar
NASDAQ Market News